Cholesgen Pharmaceutical

Private

ShanghaiHealthcare & Life Scienceshttps://cholesgen.com/

Last Round

Series A

Extension

Feb 21, 2025

Total Funding Raised

$28M

Company Overview

Cholesgen Pharmaceutical is a biopharmaceutical company that develops innovative drugs for metabolic diseases, such as hyperlipidemia, obesity, diabetes, atherosclerosis, and NASH, as well as oncology.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

drug discoverybiotechnologymetabolic diseaseoncologyfirst-in-class drugstarget identificationpreclinical researchbiopharmaNASHnonalcoholic steatohepatitisdrug licensingtherapeutic candidatessmall moleculedrug pipelinebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cholesgen Pharmaceutical Comps

Public and private peers based on sector, stage, and business model.

Cholesgen Pharmaceutical comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cholesgen Pharmaceutical Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A Extension	Feb 21, 2025
Series A	May 30, 2023
Angel	Apr 1, 2021

View all Funding Rounds

Cholesgen Pharmaceutical Investors

Notable investors and investment history

Cholesgen Pharmaceutical investors
Investor	Rounds
CICC Capital	Series A
Trinity Innovation Fund	Series A, Angel
SDIC Venture Capital	Series A Extension
Gaorong Capital	Series A
Trinity Innovation Fund	Angel, Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 21, 2025
$14M round led by SDIC Venture Capital

View all signals

Cholesgen Pharmaceutical Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cholesgen Pharmaceutical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cholesgen Pharmaceutical's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai

Year Founded2021

Last FundingFeb 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.